Introduction: Human respiratory syncytial virus (HRSV) an RNA virus belonging to Pneumoviridae family, is an important cause of acute respiratory infections (ARIs) in young children. HRSV circulates as two subgroups A and B, which are further categorised into several genotypes. New genotypes may replace existing ones over successive epidemic seasons and multiple genotypes may cocirculate in the same community rendering it important to monitor them at the molecular level. The present study assessed the circulating genotypes of HRSV in Chennai. Materials and Methods: Two hundred and sixty-seven children with ARI were recruited during the study from April 2016 to March 2018 for detecting HRSV A and B by real-time reverse transcription-polymerase chain reaction. Phylogeny and selection pressure analysis were done. Results: Fifty-seven of the 267 samples (21.3%) were positive for HRSV, of which 7.1% and 14.2% were HRSV A and B, respectively, indicating that HRSV B was the major subgroup circulating in Chennai. Peak activity of HRSV was observed during the monsoon and winter months. Phylogenetic analysis of 2 nd hypervariable region (HVR) of attachment glycoprotein gene (G gene) revealed that the HRSV A strains belonged to ON1 and HRSV B strains belonged to BA9 genotypes. Several unique amino acid substitutions were observed among the study strains. The Shannon entropy plot revealed that the HRSV A strains from our study have a high potential for amino acid substitutions in the 2 nd HVR of G gene. Conclusion: This study underlines the genetic diversity of HRSV and emphasises the need for continued molecular surveillance for infection management and prevention strategies.
intrOductiOn Human respiratory syncytial virus (HRSV) is the leading cause of death among children with acute respiratory infections (ARIs). Majority of the children are infected with HRSV by the age of 3 years. [1] In developing countries, the mortality rate in children <5 years with complications of HRSV infection is high. [2] HRSV belongs to the Pneumoviridae family. It is an enveloped virus with a linear, single-stranded negative-sense RNA which is approximately 15.2 kb in size. The genome consists of 10 genes which code for 11 proteins. The fusion (F) and the attachment glycoprotein (G) are more divergent than the other HRSV proteins. The G protein, which is involved in the attachment during viral entry, contains two hypervariable regions (HVRs): 1 st HVR and 2 nd HVR.
Based on antigenic differences in the major glycoproteins G and F using monoclonal antibodies and by genetic analysis, HRSV is divided into two subgroups -HRSV A and HRSV B, which are further classified into thirteen and twenty-eight genotypes, respectively, based on the 2 nd HVR of the G gene. The recently described ON1 genotype of HRSV A with characteristic 72 nucleotide duplication was first reported from Ontario, Canada, in 2012. The BA genotype of HRSV B (named after its first detection in Buenos Aires) possesses the characteristic 60 nucleotide insertion. These genotypes have replaced the other HRSV genotypes and have been in circulation globally. This strain variation allows the virus to cause frequent reinfections, which poses a challenge for vaccine development. [3] New genotypes may replace existing ones over successive epidemic seasons and multiple genotypes may cocirculate in the same community rendering it important to monitor them at the molecular level. [4] The present study investigates the prevalence, genetic diversity and circulatory patterns of HRSV A and B over 2 successive years (from April 2016 to March 2018) in Chennai, South India.
MaterialS and MethOdS

Clinical samples: Collection and transport
Nasal swabs were collected from 267 children aged 45 days to 16 years presenting with symptoms of ARI. The study was approved by the Institutional Human Ethics Committee. The study was conducted for 2 years from April 2016 to March 2018. Nasal swabs were collected using sterile flocked nylon swabs, by placing them 2-3 cm deep inside the nostril and rotating 2-3 times. The swabs were immediately placed in sterile viral transport medium (HiViral transport Kit, Himedia, Mumbai, India) and transported to the laboratory on ice. Swabs were gently agitated and subjected to viral RNA extraction. An aliquot of the sample was stored at −80°C for further investigations.
RNA extraction and reverse transcription
RNA was extracted from the samples using NucleoSpin RNA virus kit (Macherey Nagel, Germany) according to the manufacturer's instructions and quantified in NanoDrop spectrophotometer (Thermo Scientific, USA). The extracted RNA was subjected to reverse transcription using RevertAid first-strand cDNA synthesis kit (Thermo Scientific, USA). Briefly, a 20 µl reaction mixture consisting of 4 µl of 5× reaction buffer, 2 µl of 10 mM dNTP mix, 1 µl of Random Hexamer Primer, 1 U of Ribolock RNase inhibitor, 10 U of RevertAid M-MuLV reverse transcriptase, 5 µl of RNA and 6 µl of RNase free water was incubated for 5 min at 25°C, followed by 60 min at 42°C. The reaction was terminated by heating at 72°C for 5 min. The cDNA was stored at −20°C until use. In this study, extracted RNA was subjected to GAPDH polymerase chain reaction (PCR) to determine the quality of RNA.
Detection of human respiratory syncytial virus subtypes by real-time reverse transcription-polymerase chain reaction
Real-time reverse transcription-PCR (rRT-PCR) was applied to all the samples using primers and TaqMan probes specific for HRSV A and B [ Table 1 ]. [5] [6] [7] Simplex rRT-PCR was performed using optimised cycling parameters. Each 10 µl reaction mixture contained 5 µl of 5× FastStart Universal Probe Master (Rox), 5 picomoles each of forward and reverse primers, 2 picomoles of probe, 2 µl of cDNA and 2.4 µl of nuclease-free water. The cycling conditions were 95°C for 10 min, 45 cycles of 95°C for 15 s and 60°C for 1 min followed by 72°C for 10 s. An annealing temperature of 56°C for 1 min was used for HRSV B. Appropriate positive and negative controls were included in each run. The amplified nucleic acids were detected with the StepOnePlus Real-Time PCR System (Thermofisher Scientific, USA). The samples with C t value <40 cycles were considered to be positive.
Heminested reverse transcription-polymerase chain reaction for G protein
The 2 nd HVR of G gene of HRSV A-and HRSV B-positive samples were amplified by heminested RT-PCR using previously published primers. [8] For the first round PCR, 2 µl of cDNA was added to 18 µl master mix containing 2 µl of 10× PCR buffer, 0.25 picomoles each of forward and reverse primer, 0.15 µl of 10 mM dNTPs and 0.25 U Taq polymerase. Thermal cycling conditions for the first round were as follows: initial denaturation of 94ºC for 5 min, followed by 35 cycles of denaturation at 94°C for 30 s, annealing at 50°C for 30 s, extension at 72°C for 30 s and a final extension at 72°C for 10 min. About 1 µl of the first-round product was used as the template for the heminested PCR with same reaction mixture and thermal cycling conditions except that the annealing temperature was set at 58°C, and the PCR was carried out for 25 cycles. Positive and negative controls were included in each run. PCR products were analysed by electrophoresis with 1.5% agarose gel and visualised using the Gel documentation system (Carestream Gel logic 212 PRO) and sequenced at ImmuGenix Biosciences Pvt Ltd., Chennai, India.
Sequence analysis and phylogeny
The sequences were analysed and trimmed using the BioEdit 7.2.6 software (California, USA). [9] Nucleotide sequences of the 2 nd HVR of G gene of HRSV with known genotypes were retrieved from the GenBank for reference. All the sequences were aligned using ClustalW, and phylogenetic analysis was performed using MEGA 6 software (Pennsylvania, USA). [10] Phylogenetic trees were constructed by applying the maximum likelihood method using Kimura 2-parameter available by default in MEGA software. [11] The statistical robustness and reliability of the tree topology were analysed using 1000 bootstrapping replicates.
Mutational analysis of deduced amino acids and glycosylation site analysis
A large number of serine and threonine residues are present in the G protein of HRSV, which are potential glycosylation sites. The O-glycosylated residues and potential N-glycosylation sites (Asn -X -Ser/Thr, where X is any amino acid except Proline) were predicted using NetOGlyc (http://www.cbs. dtu.dk/services/NetOGlyc) and NetNGlyc (www.cbs.dtu.dk/ services/NetNGlyc) software, respectively. [12, 13] 
Selection pressure analysis
The selection pressure analysis in the 2 nd HVR of G protein gene of sequences belonging to ON1 and BA9 genotypes obtained in this study was estimated using the Datamonkey web server (https://www.datamonkey.org). [14, 15] Positively and negatively selected sites at each codon were estimated using the Single-Likelihood Ancestor Counting (SLAC), Fixed Effects Likelihood (FEL) and Mixed Effects Model of Evolution (MEME) methods with a cutoff P = 0.1. The selection of positive sites was also analysed using FUBAR (Fast Unconstrained Bayesian AppRoximation) method, for which a posterior probability (ß>α) ≥0.9 was considered. [16] 
Entropy analysis
Shannon entropy implemented in the Bioedit software was performed to evaluate the variability of amino acids across the 2 nd HVR of G gene of both HRSV A and HRSV B. [9, 17] In this analysis, the Shannon entropy threshold value was set to 0.2, and the range of Shannon entropy values was from 0 to 0.8. Amino acids with entropy value >0.2 were considered variable and vice versa.
Nucleotide sequence accession numbers
The sequences generated in this study are available in GenBank with accession numbers of MG962347-49 for HRSV A and MG962640-46, MH476331-48, MH500281-82 for HRSV B.
reSultS
Prevalence and seasonality
Two hundred and sixty-seven samples were tested during the study period of which 19 (7.1%) were positive for HRSV A. HRSV B was detected in 38/267 samples (14.2%). The overall prevalence of HRSV was 21.3% (57/267).
In our study, it was observed that HRSV A was the predominant subtype during April 2016 to March 2017, with all the 19 HRSV A and 5 HRSV B detected during this period. During the 2 nd year (April 2017 to March 2018), 33/38 HRSV B were detected, suggesting that HRSV B replaced HRSV A as the predominant subtype circulating during this period [ Figure 1 ]. The peak activity of HRSV A occurred in January 2017, while HRSV B was detected during the months of July 2017 to September 2017.
Sequence analysis
Three HRSV A and 27 HRSV B strains were sequenced for the 2 nd HVR of G gene, respectively. Other HRSV positive samples could not be sequenced due to the very low viral load.
Phylogeny
Phylogenetic trees were constructed by aligning the HRSV A and HRSV B sequences obtained in the present study with their respective reference sequences and sequences from India and its neighbouring countries. All the sequences were obtained from the GenBank database. Phylogenetic analysis revealed that all the three HRSV A sequences from this study clustered with the ON1 genotype [ Figure 2a ]. Similarly, all the 27 HRSV B sequences from this study clustered in BA9 genotype [ Figure 2b ]. One of the three HRSV A sequence was found to closely match with a strain from China. The second HRSV A strain closely matched with a strain from Pune and Jabalpur. The HRSV B sequences obtained in our study closely matched with HRSV B strains from Thailand and China.
Intragenotypic divergence among Indian human respiratory syncytial virus Group A and B sequences
The average intra-genotypic p-distance for ON1 and BA9 genotypes in this study were 0.029 and 0.020, respectively.
Mutational analysis of deduced amino acids and glycosylation site analysis
All the three HRSV A strains terminated with UAG stop codon with a final length of 320 amino acids and possessed nearly all the reported amino acid substitutions of prototype ON1 strain (ON67-1210A/ON1) and also several unique mutations [ Figure 3a ]. On comparing the amino acid sequence of HRSV B sequences obtained in this study with the prototype BA strain, two predicted G protein lengths of 312 (n = 22) and 319 (n = 5) amino acids were observed. These twenty-two sequences employed the stop codon UAA, whereas the remaining carried the UAG stop codon. Fifteen unique mutations were observed among one or more of our HRSV B strains [ Figure 3b ].
Glycosylation sites were identified using the NetOGlyc and NetNGlyc online software. In the HRSV A sequences, an average of 26-30 serine and threonine residues were detected which are the potential O-glycosylation sites in the 2 nd HVR of G gene. The HRSV B sequences had 13-22 potential O-glycosylation sites with a G-score of >0.5 in the 2 nd HVR of G gene.
In HRSV A, two N-linked glycosylation sites were observed in one strain at amino acid positions 237-239 and 318-320 in the second hypervariable region of the G protein. However, there was a loss of the second N-linked glycosylation site in two strains as a result of two different mutations N318T and P320A when compared with the reference A2 strain [ Figure 3a ]. All the analysed HRSV B strains carried two predicted N-linked glycosylation sites at the amino acid positions 296-298 and 310-312 [ Figure 3b ].
Table 1: Details of real-time reverse transcription-polymerase chain reaction primers and probes used in this study
Primer and Probe Sequence (5'-3') References
Selection pressure analysis
We analysed our HRSV A and B sequences for the presence of positively selected sites in the 2 nd HVR of G gene. We found that in the HRSV A sequences, two amino acids (243 and 318) were under positive selection by MEME method. However, the other methods did not detect any positive sites. Three amino acid sites (258, 261 and 281) were revealed by FEL and FUBAR methods to be under purifying selection.
In the case of HRSV B sequences, two positive sites were confirmed by two different methods: 221 and 283. However, one positive site was confirmed by three methods: 283. Five negatively selected sites were detected by FEL method.
Entropy analysis
Location of variable sites within and outside the duplicated region was detected by Shannon entropy analysis of the 2 nd HVR of the G protein of HRSV A and HRSV B strains of our study. Sixteen variable sites were detected in the HRSV A strains, of which seven were present in analogous and duplication sites at the amino acid positions 261, 273, 288, 296, 300, 302 and 303 [ Figure 4a ]. Six amino acid positions (254, 256, 267, 269, 270 and 278) in the analogous and duplication sites of the HRSV B strains were found to be variable among a total of eleven variable sites [ Figure 4b ].
diScuSSiOn
HRSV is the major cause of ARI in the paediatric population. Globally, various studies have reported the prevalence of HRSV to be ranging from 9.4% to 35%. [18] [19] [20] [21] Studies from India have documented HRSV positivity between 7.9% and 35%. [22] [23] [24] [25] [26] [27] [28] [29] The results of this study indicated that HRSV A and HRSV B cocirculated in the community during April 2016 to March 2017, with HRSV A dominating over HRSV B. In April 2017 to March 2018, only HRSV B was found in circulation. Similar patterns were observed in other parts of India. In Kerala, HRSV A was predominant during 2012 and HRSV B in 2014. [29] In Pune, HRSV A and B cocirculated in 2009 and 2010 with the latter being the predominant one. [28] However, in the same study, HRSV A replaced HRSV B as the predominantly circulating subgroup in 2012. HRSV A was the predominantly circulating subgroup during 2009-2012. During September 2012 to August 2013, HRSV A was found to be the only circulating subgroup in Jaipur, while both the groups were found to be cocirculating from September 2013 to August 2014. [28] In Chennai, from 2011 to 2014, HRSV A and HRSV B were cocirculating, and the positivity rate of HRSV A was higher than HRSV B. [25] In other studies globally, cocirculation of both the subgroups with the dominance of either has been reported.
HRSV demonstrates definite seasonality. In temperate regions, it occurs during winter and in tropical regions during monsoon. We noticed that the HRSV infections displayed seasonal variations in our study. The HRSV A activity peaked during winter and monsoon in the 1 st year of the study, while HRSV B activity occurred only during monsoon in the 2 nd year. Another study from Chennai reported that the percentage of HRSV positivity was higher during October to December in all the 4 years. [25] A study from Kerala also reported a similar pattern, with HRSV circulation predominantly observed during the monsoon season. [29] Similarly, in Jaipur, all the HRSV types were found to be circulating mainly during winter months and post-monsoon season. [28] Phylogenetic analysis revealed that all the three HRSV A strains were ON1 and all the HRSV B strains were BA9 genotype. In recent years, ON1 and different lineages of BA genotypes have been consistently reported from India and other parts of the world. HRSV A genotypes such as GA2, GA5, NA1, ON1 and HRSV B genotypes GB2, BA4, BA9, BA10 and BA12 have been documented from India till date. [8, [22] [23] [24] [25] 27, 29] A study from Chennai reported the circulation of HRSV B BA12 genotype during 2011-2014; [25] however, we did not detect any in the course of this study. Recent studies from some of the countries neighbouring India have also reported ON1 and BA9 as the predominant HRSV A and HRSV B genotypes in circulation. [20, [30] [31] [32] [33] It has been hypothesised that the numerous amino acid mutations and different glycosylation sites in the 2 nd HVR of G protein may aid the virus in escaping the host immune response. [34] The loss of one N-linked glycosylation site in two of our HRSV A strains due to different mutations has also been reported in other studies. [31] [32] [33] The two N-linked glycosylation sites observed among our HRSV B strains were consistently present among HRSV B strains from other regions of India and its neighbouring countries. [26, 32] However, loss of the second N-linked glycosylation site due to T312A mutation in some HRSV B strains has been reported from China and Thailand. [32, 33] A gain of third N-linked glycosylation site at position 253 due to D253N substitution has also been documented. [33] This modification of the number and position of the glycosylation sites may probably support the existence of certain genotypes in circulation by immune evasion mechanisms.
By Shannon entropy analysis, we found that HRSV A had more number of variable sites than HRSV B suggesting that these amino acids have a high potential for substitution. Our strains had more number of variable amino acids in the 2 nd HVR of G gene of both HRSV A and HRSV B when compared with strains from the Philippines. [35] cOncluSiOn
The major limitation of our study was that we were able to sequence only a few HRSV A strains, since other strains failed to amplify by heminested RT-PCR for G gene. However, the present study indicates a high prevalence of HRSV among children. ON1 and BA9 were the only genotypes observed among the study isolates. Despite the limitations, our study provides baseline information on the circulating genotypes in this region. The data generated from this study strongly advocates continued molecular surveillance of HRSV infections for detecting and characterising new genotypes circulating in the community.
